Lexicon Pharmaceuticals Inc’s recent filing unveils that its Former Affiliate COATS LONNEL acquired Company’s shares for reported $0.48 million on Aug 15 ’24. In the deal valued at $1.60 per share,300,000 shares were bought.
Leerink Partners downgraded its Lexicon Pharmaceuticals Inc [LXRX] rating to a Market perform from a an Outperform in a research note published on March 05, 2025; the price target was decreased to $1 from $2. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. Leerink Partners began covering LXRX with “an Outperform” recommendation on April 30, 2024. Jefferies started covering the stock on March 07, 2023. It rated LXRX as “a Hold”.
Price Performance Review of LXRX
On Monday, Lexicon Pharmaceuticals Inc [NASDAQ:LXRX] saw its stock fall -2.88% to $0.69. Over the last five days, the stock has gained 19.65%. Lexicon Pharmaceuticals Inc shares have fallen nearly -6.84% since the year began. Nevertheless, the stocks have fallen -57.27% over the past one year. While a 52-week high of $2.45 was reached on 01/24/25, a 52-week low of $0.28 was recorded on 03/03/25. SMA at 50 days reached $0.5062, while 200 days put it at $1.1417.
Levels Of Support And Resistance For LXRX Stock
The 24-hour chart illustrates a support level at 0.6453, which if violated will result in even more drops to 0.6027. On the upside, there is a resistance level at 0.7553. A further resistance level may holdings at 0.8227. The Relative Strength Index (RSI) on the 14-day chart is 66.26, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1260, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 31.84%. Stochastics %K at 77.80% indicates the stock is a holding.
How much short interest is there in Lexicon Pharmaceuticals Inc?
A steep rise in short interest was recorded in Lexicon Pharmaceuticals Inc stocks on 2025-04-15, growing by 2.07 million shares to a total of 41.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 39.26 million shares. There was a rise of 5.01%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 12, 2022 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $10 price target.
